Page last updated: 2024-08-24

remacemide and ubiquinone

remacemide has been researched along with ubiquinone in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (85.71)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borchelt, DR; Coonfield, ML; Ross, CA; Schilling, G1
Andreassen, OA; Beal, MF; Dedeoglu, A; Ferrante, KL; Ferrante, RJ; Hersch, SM; Jenkins, BG1
Bates, GP; Hockly, E1
Almqvist, EW; Aylward, EH; Field, K; Hayden, M; Kieburtz, K; McDermott, M; Raymond, LA; Rosenblatt, A; Ross, CA; Yallapragada, V1
Borchelt, DR; Chan, N; Coonfield, ML; Eaton, M; Fromholt, D; Gale, A; Morton, JL; Neslon, C; Ross, CA; Savonenko, AV; Schilling, G; Vorovich, E1
Andrzejewski, KL; Atassi, N; Auinger, P; Banno, H; Cudkowicz, ME; de Blieck, EA; Majumder, M; McDermott, MP; Murphy, A1

Reviews

1 review(s) available for remacemide and ubiquinone

ArticleYear
Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?
    Current opinion in neurology, 2003, Volume: 16, Issue:4

    Topics: Acetamides; Animals; Antioxidants; Creatine; Disease Models, Animal; Evaluation Studies as Topic; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Peptides; Point Mutation; Riluzole; Thioctic Acid; Trinucleotide Repeats; Ubiquinone

2003

Trials

2 trial(s) available for remacemide and ubiquinone

ArticleYear
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease.
    Neurology, 2001, Aug-14, Volume: 57, Issue:3

    Topics: Acetamides; Adult; Coenzymes; Double-Blind Method; Female; Humans; Huntington Disease; Male; Middle Aged; Prognosis; Time Factors; Ubiquinone

2001
Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study.
    Brain research bulletin, 2003, Dec-15, Volume: 62, Issue:2

    Topics: Acetamides; Antioxidants; Caudate Nucleus; Coenzymes; Humans; Huntington Disease; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Neuropsychological Tests; Pilot Projects; Radiography; Treatment Outcome; Ubiquinone

2003

Other Studies

4 other study(ies) available for remacemide and ubiquinone

ArticleYear
Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model.
    Neuroscience letters, 2001, Nov-27, Volume: 315, Issue:3

    Topics: Acetamides; Animals; Antioxidants; Coenzymes; Drug Therapy, Combination; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Motor Activity; Nerve Tissue Proteins; Nuclear Proteins; Peptide Fragments; Survival Analysis; Time Factors; Ubiquinone

2001
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Mar-01, Volume: 22, Issue:5

    Topics: Acetamides; Administration, Oral; Animals; Behavior, Animal; Body Weight; Brain; Cerebral Ventricles; Coenzymes; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Imaging; Male; Mice; Mice, Transgenic; Motor Activity; Nerve Tissue Proteins; Nuclear Proteins; Organ Size; Survival Rate; Treatment Outcome; Ubiquinone

2002
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice.
    Experimental neurology, 2004, Volume: 187, Issue:1

    Topics: Acetamides; Animals; Celecoxib; Chlorpromazine; Coenzymes; Cyclooxygenase Inhibitors; Disease Models, Animal; Disease Progression; Dopamine Antagonists; Environment, Controlled; Female; Humans; Huntington Disease; Mice; Mice, Transgenic; Motor Activity; Motor Skills; Neuroprotective Agents; Phenotype; Pyrazoles; Sulfonamides; Superoxide Dismutase; Superoxide Dismutase-1; Survival Rate; Treatment Outcome; Ubiquinone

2004
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials.
    Journal of Huntington's disease, 2017, Volume: 6, Issue:2

    Topics: Acetamides; Female; Humans; Huntington Disease; Kaplan-Meier Estimate; Male; Middle Aged; Minocycline; Neuroprotective Agents; Neuropsychological Tests; Patient Dropouts; Proportional Hazards Models; Randomized Controlled Trials as Topic; Ubiquinone

2017